Company Valuation: BRAIN Biotech AG

Data adjusted to current consolidation scope
Fiscal Period: September 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 141 220.7 96.35 92.63 46.32 62.92 - -
Change - 56.48% -56.34% -3.85% -50% 35.85% - -
Enterprise Value (EV) 1 152.3 217 111.8 116.1 55.58 65.63 65.11 64.17
Change - 42.42% -48.48% 3.88% -52.14% 18.09% -0.78% -1.45%
P/E ratio -13.7x -40.4x -14.7x -11.2x -4.16x -10.1x -26.7x -85.5x
PBR 6.78x 5.69x 3.25x 4.25x 3.67x 3.98x 3.22x 7.13x
PEG - 0.8x -0.7x -0.4x -0.1x 0.2x 0.4x 1.2x
Capitalization / Revenue 3.6x 5.75x 1.95x 1.67x 0.85x 1.04x 0.96x 0.89x
EV / Revenue 3.89x 5.65x 2.26x 2.1x 1.02x 1.08x 0.99x 0.91x
EV / EBITDA -76.2x -86.8x -85.4x -141x -13.9x 15.4x 10.4x 7x
EV / EBIT -18.5x -33.1x -19.8x -21.2x -6.28x -178x 44.2x 16.2x
EV / FCF -20x -42x -14.8x -16.9x -10.5x -14.6x -34.3x 642x
FCF Yield -5.01% -2.38% -6.77% -5.9% -9.56% -6.86% -2.92% 0.16%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.52 -0.25 -0.3 -0.38 -0.51 -0.2847 -0.1079 -0.0337
Distribution rate - - - - - - - -
Net sales 1 39.2 38.4 49.5 55.34 54.6 60.73 65.56 70.71
EBITDA 1 -2 -2.5 -1.309 -0.826 -4 4.267 6.285 9.171
EBIT 1 -8.229 -6.548 -5.648 -5.48 -8.852 -0.3679 1.473 3.949
Net income 1 -9.684 -4.972 -6.59 -8.279 -11.13 -6.152 -2.298 3.648
Net Debt 1 11.32 -3.698 15.43 23.48 9.259 2.708 2.193 1.249
Reference price 2 7.100 10.100 4.410 4.240 2.120 2.880 2.880 2.880
Nbr of stocks (in thousands) 19,861 21,847 21,847 21,847 21,847 21,847 - -
Announcement Date 1/14/21 1/17/22 1/16/23 1/17/24 1/15/25 - - -
1EUR in Million2EUR
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio (N) EV / Sales (N) EV / EBITDA (N) Yield (N) Capi.($)
-10.12x1.08x15.38x-.--% 65.07M
-3.07x10.06x-8.01x-.--% 155M
Average -6.59x 5.57x 3.68x percentage-no-prefix 110.03M
Weighted average by Cap. -5.15x 7.40x -1.10x percentage-no-prefix
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. BNN Stock
  4. Valuation BRAIN Biotech AG